India
· Delayed Price · Currency is INR Mankind Pharma Statistics
Total Valuation
Mankind Pharma has a market cap or net worth of INR 1.05 trillion. The enterprise value is 1.01 trillion.
| Market Cap | 1.05T |
| Enterprise Value | 1.01T |
Important Dates
The last earnings date was Tuesday, February 4, 2025.
| Earnings Date | Feb 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Mankind Pharma has 412.57 million shares outstanding. The number of shares has increased by 0.20% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 412.57M |
| Shares Change (YoY) | +0.20% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 57.75% |
| Owned by Institutions (%) | 16.23% |
| Float | 105.87M |
Valuation Ratios
The trailing PE ratio is 50.29 and the forward PE ratio is 47.21. Mankind Pharma's PEG ratio is 2.71.
| PE Ratio | 50.29 |
| Forward PE | 47.21 |
| PS Ratio | 8.80 |
| PB Ratio | 9.69 |
| P/TBV Ratio | 11.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 2.71 |
Enterprise Valuation
| EV / Earnings | 49.67 |
| EV / Sales | 8.71 |
| EV / EBITDA | 34.84 |
| EV / EBIT | 41.06 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.17 |
| Debt / FCF | n/a |
| Interest Coverage | 10.10 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 15.29% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 5.96M |
| Profits Per Employee | 1.04M |
| Employee Count | 19,540 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.85% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +26.85% |
| 50-Day Moving Average | 2,679.89 |
| 200-Day Moving Average | 2,425.93 |
| Relative Strength Index (RSI) | 46.81 |
| Average Volume (20 Days) | 645,069 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mankind Pharma had revenue of INR 116.41 billion and earned 20.41 billion in profits. Earnings per share was 50.81.
| Revenue | 116.41B |
| Gross Profit | 81.70B |
| Operating Income | 24.57B |
| Pretax Income | 25.86B |
| Net Income | 20.41B |
| EBITDA | 28.93B |
| EBIT | 24.57B |
| Earnings Per Share (EPS) | 50.81 |
Balance Sheet
The company has 47.27 billion in cash and 4.82 billion in debt, giving a net cash position of 42.45 billion or 102.88 per share.
| Cash & Cash Equivalents | 47.27B |
| Total Debt | 4.82B |
| Net Cash | 42.45B |
| Net Cash Per Share | 102.88 |
| Equity (Book Value) | 107.89B |
| Book Value Per Share | 263.72 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.18%, with operating and profit margins of 21.11% and 17.54%.
| Gross Margin | 70.18% |
| Operating Margin | 21.11% |
| Pretax Margin | 22.21% |
| Profit Margin | 17.54% |
| EBITDA Margin | 24.85% |
| EBIT Margin | 21.11% |
| FCF Margin | n/a |
Dividends & Yields
Mankind Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.20% |
| Shareholder Yield | -0.20% |
| Earnings Yield | 1.94% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |